Deviating from safety guidelines during deferiprone therapy...

Pediatric Blood & Cancer 2014 / 05 Vol. 61; Iss. 5

Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis

Elalfy, Mohssen, Wali, Yasser A., Qari, Mohamad, Al Damanhouri, Ghazi, Al-Tonbary, Youssef, Yazman, Dilek, Al Hawsawi, Zakaria, Karakas, Zeynep, Kilinc, Yurdanur, Yesilipek, M. Akif, Badr, Mohamed, El
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
61
Language:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.24920
Date:
May, 2014
File:
PDF, 717 KB
english, 2014
Conversion to is in progress
Conversion to is failed